The management of non-CF bronchiectasis in Europe: data from the European Bronchiectasis Network

James D. Chalmers (Perth, United Kingdom)

Source: International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC)

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
James D. Chalmers (Perth, United Kingdom). The management of non-CF bronchiectasis in Europe: data from the European Bronchiectasis Network. International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC)

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Management of bronchiectasis in Europe: Data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2016 – Clinical update on bronchiectasis
Year: 2016

Heterogeneity in bronchiectasis service provision in Europe: Baseline data from the European bronchiectasis registry (EMBARC)
Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical aspects and research outlook
Year: 2015

Asthma as a co-morbidity and cause of bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Phenotyping of adult patients with bronchiectasis and Yellow-Nail-Syndrome (YNS)- data from the German and the European Bronchiectasis Registries (PROGNOSIS and EMBARC)
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019


Research priorities in bronchiectasis: A consensus from the European multicentre bronchiectasis audit and research collaboration (EMBARC) study group
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015


Impact of bronchiectasis on severe asthma: data from the “Severe Asthma Network Italy” (SANI) registry
Source: International Congress 2018 – Determinants and monitoring of asthma control
Year: 2018



Long term clinical outcomes of bronchiectasis in India: Data from the EMBARC/RRNI Indian Bronchiectasis Registry
Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Year: 2021



New isolation of non-tuberculous mycobacteria in patients with bronchiectasis - data from the European Bronchiectasis Registry (EMBARC)
Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection
Year: 2019

Challenges in the management of non-CF bronchiectasis
Source: International Congress 2016 – Challenges in the management of non-CF bronchiectasis
Year: 2016

Rheumatoid arthritis is a common and important comorbidity in bronchiectasis: Data from the EMBARC European bronchiectasis registry
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016

Mucus clearance devices in bronchiectasis: Indian experience
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013

Treatment of patients with idiopathic pulmonary fibrosis in real-life setting: Results from the Latin American Pulmonary Fibrosis Registry REFIPI
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019


European Respiratory Society guidelines for the management of adult bronchiectasis
Source: Guideline 2017
Year: 2017

European Respiratory Society guidelines for the management of adult bronchiectasis
Source: Eur Respir J, 50 (3) 1700629; 10.1183/13993003.00629-2017
Year: 2017



Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network
Source: Eur Respir J, 51 (1) 1701937; 10.1183/13993003.01937-2017
Year: 2018



Clinical cases: COPD and bronchiectasis
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017

The European IPF Registry: Addressing challenges and characteristics of patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Year: 2018




Disease entities and microbiological results of 430 patients with non-CF bronchiectasis - Target for new diagnostics and therapies?
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016


The microbiology of stable bronchiectasis: data from the EMBARC bronchiectasis registry
Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes
Year: 2021